• Journal Article

OBSERVE 5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis ? final 5 year results

Citation

Rothman, K., Kricorian, G., Pariser, D., Yamauchi, P., Menter, A., Teller, C., ... Gelfand, J. M. (2014). OBSERVE 5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis ? final 5 year results. Journal of the American Academy of Dermatology.

Abstract